Antibodies against a surface protein of Streptococcus pyogenes promote a pathological inflammatory response.
Antibodies against a surface protein of Streptococcus pyogenes promote a pathological inflammatory response.
复制标题
对链球菌为链球菌表面蛋白的抗体促进病理炎症反应。
DOI:
10.1371/journal.ppat.1000149
复制
发表时间:
2008-09-12
期刊:
影响因子:
6.7
通讯作者:
Bjorck, Lars
中科院分区:
文献类型:
--
作者:
Kahn, Fredrik;Morgelin, Matthias;Shannon, Oonagh;Norrby-Teglund, Anna;Herwald, Heiko;Olin, Anders I.;Bjorck, Lars
Streptococcal toxic shock syndrome (STSS) caused by Streptococcus pyogenes is a clinical condition with a high mortality rate despite modern intensive care. A key feature of STSS is excessive plasma leakage leading to hypovolemic hypotension, disturbed microcirculation and multiorgan failure. Previous work has identified a virulence mechanism in STSS where M1 protein of S. pyogenes forms complexes with fibrinogen that activate neutrophils to release heparin-binding protein (HBP), an inducer of vascular leakage. Here, we report a marked inter-individual difference in the response to M1 protein–induced HBP release, a difference found to be related to IgG antibodies directed against the central region of the M1 protein. To elicit massive HBP release, such antibodies need to be part of the M1 protein–fibrinogen complexes. The data add a novel aspect to bacterial pathogenesis where antibodies contribute to the severity of disease by promoting a pathologic inflammatory response. Streptococcus pyogenes, also known as group A streptococcus, is a common bacterial pathogen mostly causing rather harmless infections such as pharyngitis (“strep throat”) and impetigo (a superficial skin infection). However, sometimes these bacteria give rise to severe invasive infections, and one of the most feared conditions in infection medicine is streptococcal toxic shock syndrome (STSS). In STSS, the mortality remains high despite modern intensive care and the fact that S. pyogenes is susceptible to penicillin. Why some people develop this serious condition and others not is still not fully understood. The common dogma is that antibodies against a pathogenic microorganism are protective, but in this work we show that certain antibodies actually increase the risk for a more severe disease. This information suggests that these antibodies could be used as therapeutic targets, and the results may also facilitate the identification of individuals prone to developing STSS.
登录
查看更多内容
影响因子:
6.4
作者:
Bryant, AE;Bayer, CR;Stevens, DL
通讯作者:
Stevens, DL
影响因子:
3.1
作者:
Collin, M;Olsén, A
通讯作者:
Olsén, A
影响因子:
4.4
作者:
Batzloff, Michael R.;Pandey, Manisha;Good, Michael F.
通讯作者:
Good, Michael F.
影响因子:
3.6
作者:
Collin, M;Olsén, A
通讯作者:
Olsén, A
影响因子:
3.2
作者:
Edens, HA;Parkos, CA
通讯作者:
Parkos, CA